Delivery Order SPE2DB24D3015-SPE2DB24FFXJL

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Carvedilol ER 40 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $1,345.98, was awarded on November 6, 2023, with a completion date of November 7, 2023. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award is for the delivery of Carvedilol ER 40 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $14,732.77. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Carvedilol ER 10 mg capsules to the Defense Logistics Agency (DLA), which is part of the U.S. Department of Defense (DoD). The contract, valued at $3,072.18, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a firm fixed-price basis. The contract has a completion date of July 16, 2024 and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award is for the delivery of Carvedilol ER 20 mg capsules in quantities of 30 to the Defense Logistics Agency (DLA). The $1,077.66 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 13, 2025, with a completion date of February 14, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with DLA Troop Support Medical, which...
This federal contract award is for the delivery of Carvedilol ER 10 mg capsules in quantities of 30s to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, in the amount of $5,711.40 on April 19, 2024, with a completion date of April 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award is for the delivery of Carvedilol ER 40 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price type, valued at $4,227.55, with an ultimate completion date of January 16, 2024. The contract was awarded on January 12, 2024, and there was no set-aside designation used. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of 4566769885 Carvedilol ER 20 mg capsules in packages of 30 to the Defense Logistics Agency (DLA). The $2,324.61 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 19, 2024, with a completion date of December 20, 2024. The contract is a delivery order awarded under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,173.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen is the prime contractor and has been awarded numerous federal contracts by the DLA and...
This federal contract award is for the delivery of Carvedilol ER 10 mg capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,923.50, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November...
This federal contract award is for the delivery of Carvedilol ER 40 mg capsules to the Defense Logistics Agency (DLA). The contract, worth $1,098.58, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB24FFXJL
    Delivery Order

This federal contract award is for the supply of Carvedilol ER 40 mg capsules in 30-count packages. The contract, valued at $3,373.22, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a delivery order, with a firm-fixed price pricing type, and does not have a set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA for the provision of a wide range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of August 20, 2024.

Generated 11/18/24, 9:20 AM